Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis seeks European approval for cell therapy Kymriah
Novartis seeks European approval for cell therapy Kymriah
Novartis seeks European approval for cell therapy Kymriah
Submitted by
admin
on November 6, 2017 - 9:25am
Source:
Reuters
News Tags:
Novartis
Europe
CAR-T
Kymriah
diffuse large B-cell lymphoma
acute lymphoblastic leukemia
Headline:
Novartis seeks European approval for cell therapy Kymriah
Do Not Allow Advertisers to Use My Personal information
